News Focus
News Focus
icon url

Neophius

02/29/20 11:30 AM

#36947 RE: trader59 #36946

Wrong.

This is not a 1 cent stock. I’ve explained multiple times that you don’t derive valuation from a singular purchase. The most we can say is that valuation is currently incomplete, as the most relevant reports haven’t been released yet (annual/q1).

Also, CareClix is in its infancy from SOLI’s perspective. We don’t know what impact recent deals have had, nor the impact of a larger sales staff.

Dilution has been an issue, but the share issuances are mostly from employee compensation and known convertibles. The majority is still restricted.

None of this has been a mystery.

icon url

DTGoody

02/29/20 11:48 AM

#36949 RE: trader59 #36946

Lets try not to spin this:

The OS is at 205,670,136 shares as of 2/25/2020. However they have not been selling those shares onto the open market. Instead The Restricted Share count has been increasing, and not the Float. The Restricted share count is now at 168,386,333 as of 02/25/2020. The Float has only increased by a couple million shares since the acquisition of CareClix. The current float is only at 37,106,936 million shares as of 01/28/2020. Very little has been sold onto the open market.

This tells me that the company officers must be financing the debt themselves and placing those shares into the restricted share count and not selling them on the open market at this time.

Once contracts and revenues start to increase SOLI should start to see some very nice gains with the current float at just 37 million shares.